1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)


Table 1: 
Baseline characteristics of patients with BAVM
Total Patients (n = 83)
Age (mean) (yr)30.2 (SD, 11.5)
Sex (No.) (%)
 Male53 (62.4)
 Female30 (37.6)
Lobe (No.) (%)
 Frontal37 (44.6)
 Temporal18 (21.7)
 Parietal18 (21.7)
 Occipital8 (9.6)
 Insula2 (2.4)
Size (mean) (mm)35.1 (SD, 11.4)
Deep perforating artery supply (No.) (%)22 (26.5)
Deep venous drainage (No.) (%)7 (8.4)
Diffuse nidus (No.) (%)25 (30.1)
LCDAI (mean) (mm)4.3 (SD, 5.1)
Hemorrhage (No.) (%)33 (39.8)
Seizure (No.) (%)41 (49.4)
S-M score (No.) (%)2.4 (SD, 0.9)